Griseofulvin
- Strength
- 125 mg/5mL
- Form
- Suspension
- Class
- Tubulin Inhibiting Agent
Cosette Pharmaceuticals, Inc.
griseofulvin
Listed by Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Tubulin Inhibiting Agent |
| Approval route | ANDA — approved generic |
| NDC code | 23155-865 |
| FDA application | ANDA060569 |
| RxNorm concept | 310600 |
| Package sizes listed | 1 |
| Marketed since | June 2023 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Cosette Pharmaceuticals, Inc.
Sandoz Inc
Sandoz Inc
Griseofulvin (microsize)
Chartwell RX, LLC.
Sigmapharm Laboratories, LLC
Actavis Pharma, Inc.
griseofulvin
Chartwell RX, LLC.
Cipla USA Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.